The Worldwide Healthcare Fraud Detection Industry is Projected to Reach $3.6 Billion by 2031

2022-12-29
PRNewswire
DUBLIN, Dec. 29, 2022 /PRNewswire/ -- The "Healthcare Fraud Detection Market By Type, By Component, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to
ResearchAndMarkets.com's offering.
The global healthcare fraud detection Market was valued at $1,098.2 million in 2021, and is projected to reach $3,600.0 million by 2031, registering a CAGR of 12.6% from 2022 to 2031.
The goal of fraud detection is to stop someone from obtaining money or other items through deceptive means. Various industries, including medical and healthcare, use fraud detection techniques. healthcare fraud detection involves account audits and detective work. A thorough account audit might discover suspect policy holders and suppliers. It is ideal to carefully audit each and every claim one at a time.
However, there are no realistic way to audit all claims. Fraud detection management is done by the techniques such as to look through millions of transactions, classify, organize, and segment data in order to locate patterns and identify fraud, data mining, estimation of the connections between independent and dependent variables. Data matching is a technique used to compare two collections of data, remove out duplicates, and establish connections between data.
Healthcare fraud, waste, and abuse are actually prevented by the healthcare fraud detection industry. Healthcare fraud is the deliberate distortion of facts by patients or healthcare personnel that results in unlawful payments or benefits.
Examples of healthcare fraud include the filing of numerous claims by different providers for the same patients, the falsification of data by doctors, the submission of claims for services that have not been rendered, and the misrepresentation of dates for various treatments, frequency, duration, or service descriptions. The various activities involving fraud in medical industries has increased. Furthermore, the increased fraud cases, abuse of medical products and equipment and misuse of healthcare funds is projected to drive the market growth.
The major factor that drives the market growth of healthcare fraud detection in healthcare market is increase in number of patients seeking health insurance. The other factors such as increase in fraudulent cases, and misuse of funds offered by healthcare boost the growth of the healthcare fraud detection market. A small number of auditors must manually evaluate and pinpoint the dubious medical insurance claims to manually discover healthcare fraud.
However, more effective and automated methods of detecting healthcare frauds have been developed because to recent breakthroughs in machine learning and data mining techniques. In recent years, there has been an increase in interest in mining healthcare data for fraud detection also boosting the global healthcare fraud detection market. The breakthrough advances in machine learning and artificial intelligence, increased in data security concern in healthcare industry restraining the global healthcare fraud detection market.
The healthcare fraud detection market segmented on the basis of type, component, application, end user and region. By type, the market is segmented into descriptive analytics, predictive analytics and prescriptive analysis. By component the market is fragmented into service and software. By application the market divided into insurance claims review and payment integrity.
By end user, the market is segmented into healthcare payer, government agencies and others. The healthcare payer further segmented into public payer and private payer. The others segment includes employers, healthcare providers and third-party service providers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major key players that operate in the global healthcare fraud detection market are International Business Machines Corporation (IBM), Optum, Verscend Technologies, McKesson Corporation, FAIR ISAAC Corporation, SAS Institute Inc., HCL Technologies, Wipro Limited, Conduent, CGI Group, DXC Technology Company, UnitedHealth Group, Exlservice Holdings Inc., Scio inspire Corp, LexisNexis, OSP Labs, Northrop Grumman.
Key Benefits
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the healthcare fraud detection market analysis from 2021 to 2031 to identify the prevailing healthcare fraud detection market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the healthcare fraud detection market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global healthcare fraud detection market trends, key players, market segments, application areas, and market growth strategies.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: HEALTHCARE FRAUD DETECTION MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Descriptive Analytics
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Predictive Analytics
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Prescriptive Analysis
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: HEALTHCARE FRAUD DETECTION MARKET, BY COMPONENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Services
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Software
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: HEALTHCARE FRAUD DETECTION MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Insurance Claims Review
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Payment Integrity
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: HEALTHCARE FRAUD DETECTION MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Healthcare Payer
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.2.4 Healthcare Payer Healthcare Fraud Detection Market by Type
7.2.4.1 Public Payers Market size and forecast, by region
7.2.4.2 Private players Market size and forecast, by region
7.3 Government Agencies
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: HEALTHCARE FRAUD DETECTION MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Verscend Technologies
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 WIPRO LIMITED
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Conduent
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 CGI Group
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Exlservice Holdings Inc.
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Cotiviti Inc.
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 OSP Labs
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 Northrop Grumman
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
For more information about this report visit https://www.researchandmarkets.com/r/ixxx0f
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。